Patent ID: 8263091
Filing Date: 2012-09-11
Classification: A61K,C07K,Y02A

Abstract:
1. A method of increasing an immune response to an opportunistic infection in an immunocompromised subject comprising selecting an immunocompromised subject infected with a secondary infection, wherein the immunocompromised subject is immunocompromised as a result of an infection with human immunodeficiency virus (HIV) or a simian immunodeficiency virus (SIV), and wherein the secondary infection is infection with a administering to the immunocompromised subject infected with the secondary infection a therapeutically effective amount of an oligodeoxynucleotide comprising the nucleic acid sequence set forth as SEQ ID NO: 176, an oligodeoxynucleotide comprising the nucleic acid sequence set forth as SEQ ID NO: 177 and an oligodeoxynucleotide comprising the nucleic acid sequence set forth as SEQ ID NO: 178; and assessing the immune response to the thereby increasing the response to the